Earnings roundup: Neurocrine slumps, Alnylam battles skeptics and Ascendis eyes a competitor

13 2 月, 2026

One Min Read

8 Views

原文: https://finance.yahoo.com/news/earnings-roundup-neurocrine-slumps-alnylam-172300252.html

Last Update: 13 2 月, 2026

Written By

Other Articles

Previous

Trump tariffs leave importers with record-breaking $3.5 billion U.S. Customs bond funding shortfall

Next

Lincoln Electric (LECO) Earnings Call Transcript

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept